| NOVO-NORDISK AS B DK 0,1 |
| Dänemark |
| Gesundheit |
| DK0062498333 / A3EU6F |
| NOV (Frankfurt) |
| FRA:NOV, ETR:NOV, NOV:GR |
| - |
| https://www.novonordisk.c.. |
|
Novo Nordisk A/S is a global pharmaceutical company specializing in research, development, and manufacturing of treatments for serious chronic diseases. Founded through the 1989 merger of Danish insulin pioneers Nordisk Insulaboratorium and Novo Tera..
>Volltext.. |
| 156473.14 Mio. EUR |
| 170375.15 Mio. EUR |
| 41403.99 Mio. EUR |
| 20086.82 Mio. EUR |
| 13722.65 Mio. EUR |
| 3.09 EUR |
| 17543.88 Mio. EUR |
| 3545.27 Mio. EUR |
| 15955.59 Mio. EUR |
| 0.13 |
| 6.34% |
| 1.35% |
| 1.57 EUR |
| 4.44% |
| 4.44% |
| 27.03.26 - 1.064076€ 15.08.25 - 0.502445€ >weitere anzeigen... |
| - |
| NOVO NORDISK, NOVONORDISK |
| 29.04.26 |
|